Tempest Therapeutics TPST
NASDAQ TPST
$0.39 -0.01 (-2.17%)
As of: Nov 12, 2026 · 2:18 PM EST

Tempest Therapeutics (TPST) Return on Sales [ROS] (2013 - 2020)

Updated

Tempest Therapeutics' Return on Sales [ROS] was -14192.73% in Q3 2018, up 2603.70 percentage points from -16796.43% a year earlier but down 8037.17 percentage points from the prior quarter.

Analysis

Tempest Therapeutics (TPST) Return on Sales [ROS] (2013 - 2020) Analysis & Trends

On a trailing twelve-month basis, Tempest Therapeutics' Return on Sales [ROS] was -20266.67% through Sep 30, 2018, down 423.77 percentage points year-over-year; for FY2017, it was -28585.08%, down 16178.96 percentage points from FY2016.

  • In earlier years, Return on Sales [ROS] was -12406.13% in FY2016 (+13586.29 pp) and -25992.42% in FY2015.
  • Quarterly Return on Sales [ROS] has moved between -112086.67% (Q1 2015) and -6155.56% (Q2 2018) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has increased for three straight quarters, with an average year-over-year change of -3330.21 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2016 (a gain of 97402.42 percentage points); the worst was Q4 2017 (a drop of 28111.85 percentage points).
  • Per Business Quant data, TPST's Return on Sales [ROS] in the three quarters before Q3 2018 was -6155.56% (Q2 2018), -6549.25% (Q1 2018) and -46597.80% (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Tempest Therapeutics 5.91 Mn -11.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -29,814.19%
Sep 30, 2020 -7,483.38%
Jun 30, 2020 -104,760.00%
Mar 31, 2020 -7,490.74%
Dec 31, 2019 -7,459.88%
Sep 30, 2019 -4,937.39%
Jun 30, 2019 -3,246.01%
Mar 31, 2019 -3,383.17%
Dec 31, 2018 -24,883.33%
Sep 30, 2018 -14,192.73%
Jun 30, 2018 -6,155.56%
Mar 31, 2018 -6,549.25%
Dec 31, 2017 -46,597.80%
Sep 30, 2017 -16,796.43%
Jun 30, 2017 -21,345.24%
Mar 31, 2017 -23,153.97%
Dec 31, 2016 -18,485.95%
Sep 30, 2016 -9,626.40%
Jun 30, 2016 -9,651.32%
Mar 31, 2016 -14,684.25%
API Access

Tempest Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TPST&period=max&api_key=YOUR_API_KEY